Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Severe sepsis and septic shock].

J Delaloye1, J-D Baumgartner, T Calandra

  • 1Service des maladies infectieuses Département de médecine CHUV, 101 I Lausanne.

Revue Medicale Suisse
|May 6, 2006
PubMed
Summary

Severe sepsis and septic shock are significant ICU admissions, with increasing incidence. While understanding has grown, new therapies like early-goal directed therapy show promising results for these critical conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Invasive Pulmonary Aspergillosis in Intensive Care Units: Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS).

Mycoses·2025
Same author

Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.

The Journal of infection·2022
Same author

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.

Scientific reports·2019
Same author

Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.

HIV medicine·2019
Same author

Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Pathophysiology

Background:

  • Severe sepsis and septic shock are common ICU admissions, representing 11% of cases.
  • Septic shock is a leading cause of mortality in non-coronary ICUs.
  • Sepsis incidence in the US rose by 8.7% annually from 1979-2000.

Purpose of the Study:

  • To review the current understanding of sepsis and septic shock pathogenesis.
  • To highlight recent therapeutic advancements in managing severe sepsis and septic shock.
  • To assess the impact of novel treatments on patient outcomes.

Main Methods:

  • Literature review of recent studies on sepsis and septic shock.
  • Analysis of epidemiological data on sepsis incidence and mortality.
  • Evaluation of emerging therapeutic strategies and their clinical results.

Main Results:

  • Despite advances in understanding pathogenesis, effective treatments remain a challenge.
  • New therapeutic approaches, including early-goal directed therapy, have shown encouraging outcomes.
  • Activated protein C, corticosteroids, and intensive insulin therapy are among the promising interventions.

Conclusions:

  • Severe sepsis and septic shock continue to pose a major challenge in intensive care.
  • Recent therapeutic innovations offer hope for improved patient management and outcomes.
  • Continued research into host defense and pathogenesis is crucial for future treatment development.

Related Experiment Videos